查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585675

果冻市场：按产品、来源、应用和最终用户 - 2025-2030 年全球预测

Biosurgery Market by Product (Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents), Source (Biologics Products, Synthetic Products), Application, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年果冻市场价值为151.3亿美元，预计到2024年将达到163.5亿美元，复合年增长率为8.17%，到2030年将达到262.2亿美元。

果冻市场专注于有助于止血、封闭和组织修復的生物衍生外科产品的开发和应用。该领域对于改善手术结果、降低手术风险和促进康復至关重要。在人口老化、外科手术增加和技术进步的推动下，该市场有望成长，但面临高成本和严格监管等挑战。果冻可应用于各种外科手术，包括整形外科、心血管外科和神经外科，最终使用者是医院、诊所和门诊手术中心。成长主要归因于对微创手术的日益关注、新兴市场的扩张以及全球医疗基础设施的改善。商业机会在于开发下一代、具成本效益和有效的产品，这些产品反映了生物相容性材料和再生医学的进步。然而，市场成长受到定价压力、报销问题和高资本投资要求的阻碍。一个显着的限制是，由于意识和基础设施不足，在欠发达地区采用缓慢。新的商机包括组织支架的创新、生物活性创伤护理产品以及利用生物技术进步的个人化医疗方法的开发。公司可以透过投资加强生医材料的研发并利用与研究机构的策略联盟来加速技术进步，从而利用这些前景。此外，在医疗支出不断增加的新兴国家扩大销售网络也可能是可行的成长策略。促进与医疗保健提供者的伙伴关係以及提高产品的可用性和可负担性将发挥关键作用。保持适应不断变化的法规并专注永续实践将进一步确保竞争格局的弹性。毕竟，市场动态是动态和竞争的，创新和监管敏捷性是持续成功的关键。

主要市场统计
基准年[2023] 151.3亿美元
预测年份 [2024] 163.5亿美元
预测年份 [2030] 262.2亿美元
复合年增长率（%） 8.17%

市场动态：揭示快速发展的果冻市场的关键市场洞察

供需的动态交互作用正在改变果冻市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 老年人口增加及微创手术增加
    • 患者对有效控制出血的需求日益增加
    • 政府加大对果冻的投资
  • 市场限制因素
    • 对果冻高成本的担忧
  • 市场机会
    • 介绍利用尖端技术的果冻产品
    • 医疗旅游的潜在发展和对先进生物材料日益增长的需求
  • 市场挑战
    • 严格的法律规范和缺乏临床专业知识

波特的五力：驾驭果冻市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解果冻市场的外部影响

外部宏观环境因素在塑造果冻市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解果冻市场的竞争状况

对果冻市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵果冻市场供应商绩效评估

FPNV定位矩阵是评估果冻市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了果冻市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，果冻市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化的加剧和微创手术的增加
      • 对有效患者失血管理的需求增加
      • 政府加大对果冻的投资
    • 抑制因素
      • 对果冻高成本的担忧
    • 机会
      • 介绍先进的、技术主导的果冻产品
      • 医疗旅游的潜在发展和对先进生物材料不断增长的需求
    • 任务
      • 严格的法规结构和缺乏临床专业知识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章果冻市场：副产品

  • 防沾黏屏障
  • 骨移植附件
  • 止血剂
  • 软组织附着
  • 手术密封剂

第七章果冻市场：依来源分类

  • 生技药品
  • 合成产品

第八章果冻市场：依应用分类

  • 心血管外科
  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科
  • 胸腔外科
  • 泌尿系统

第九章果冻市场：依最终用户分类

  • 诊所
  • 医院

第十章美洲果冻市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太果冻市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的果冻市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aroa Biosurgery Limited
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cabaletta Bio, Inc.
  • CSL Limited
  • Getinge AB
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services Inc.
  • Kuros Bioscience AG
  • Medtronic PLC
  • Ocular Therapeutix, Inc.
  • Orthofix Medical, Inc.
  • Pfizer Inc.
  • RTI Surgical, Inc.
  • Samyang Holdings Corporation
  • Sanofi SA
  • Smith & Nephew plc
  • Stryker Corporation
  • Tissue Regenix Ltd
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-AD36CD8982F7

The Biosurgery Market was valued at USD 15.13 billion in 2023, expected to reach USD 16.35 billion in 2024, and is projected to grow at a CAGR of 8.17%, to USD 26.22 billion by 2030.

The biosurgery market focuses on the development and application of biologically-originated surgical products, aiding in hemostasis, sealing, and tissue repair. This segment is critical for enhancing surgical outcomes, reducing operative risks, and accelerating recovery. Driven by an aging population, increasing surgical procedures, and technological advancements, the market is poised for growth, yet it faces challenges such as high costs and stringent regulatory scrutiny. Biosurgery finds applications in various surgeries, including orthopedic, cardiovascular, and neurosurgeries, with end-users being hospitals, clinics, and ambulatory surgical centers. Growth is predominantly fueled by an increasing focus on minimally invasive procedures, expansion in emerging markets, and improved healthcare infrastructure globally. Opportunities lie in the development of cost-effective and effective next-generation products, reflecting advances in biocompatible materials and regenerative medicine. However, market growth is hampered by pricing pressures, reimbursement issues, and a high capital investment requirement. A noteworthy limitation is the slow adoption in underdeveloped regions due to inadequate awareness and infrastructure. Emerging opportunities include innovations in tissue scaffolding, bioactive wound care products, and development of personalized medicine approaches leveraging biotechnological advancements. Companies can capitalize on these prospects by investing in R&D for enhanced biomaterials and leveraging strategic collaborations with research institutes to foster technological advancements. Additionally, expanding distribution networks in emerging economies where healthcare expenditure is rising can be a viable growth strategy. Fostering partnerships with healthcare providers to enhance product accessibility and affordability will play a crucial role. Staying adaptive to changing regulations and focusing on sustainable practices may further ensure resilience in a competitive landscape. Ultimately, the biosurgery market's nature is dynamic and highly competitive, with innovation and regulatory agility being keys to sustained success.

KEY MARKET STATISTICS
Base Year [2023] USD 15.13 billion
Estimated Year [2024] USD 16.35 billion
Forecast Year [2030] USD 26.22 billion
CAGR (%) 8.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biosurgery Market

The Biosurgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and increase in the volume of minimal-invasive surgeries
    • Growing need for effective blood loss management in patients
    • Increase in investments by the government in the biosurgery
  • Market Restraints
    • Concern associated with high cost of biosurgery
  • Market Opportunities
    • Introduction of advanced and tech-driven biosurgery products
    • Potential development of medical tourism and rise in need for advanced bio materials
  • Market Challenges
    • Stringent regulatory framework and dearth of clinical expertise

Porter's Five Forces: A Strategic Tool for Navigating the Biosurgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biosurgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biosurgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biosurgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biosurgery Market

A detailed market share analysis in the Biosurgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biosurgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biosurgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biosurgery Market

A strategic analysis of the Biosurgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biosurgery Market, highlighting leading vendors and their innovative profiles. These include Aroa Biosurgery Limited, Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Boston Scientific Corporation, Cabaletta Bio, Inc., CSL Limited, Getinge AB, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Kuros Bioscience AG, Medtronic PLC, Ocular Therapeutix, Inc., Orthofix Medical, Inc., Pfizer Inc., RTI Surgical, Inc., Samyang Holdings Corporation, Sanofi SA, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Ltd, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents, Soft Tissue Attachments, and Surgical Sealants.
  • Based on Source, market is studied across Biologics Products and Synthetic Products.
  • Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecology Surgery, Neurological Surgery, Orthopedic Surgery, Thoracic Surgery, and Urology Surgery.
  • Based on End-Users, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and increase in the volume of minimal-invasive surgeries
      • 5.1.1.2. Growing need for effective blood loss management in patients
      • 5.1.1.3. Increase in investments by the government in the biosurgery
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with high cost of biosurgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced and tech-driven biosurgery products
      • 5.1.3.2. Potential development of medical tourism and rise in need for advanced bio materials
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of clinical expertise
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biosurgery Market, by Product

  • 6.1. Introduction
  • 6.2. Adhesion Barriers
  • 6.3. Bone Graft Attachments
  • 6.4. Hemostatic Agents
  • 6.5. Soft Tissue Attachments
  • 6.6. Surgical Sealants

7. Biosurgery Market, by Source

  • 7.1. Introduction
  • 7.2. Biologics Products
  • 7.3. Synthetic Products

8. Biosurgery Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Gynecology Surgery
  • 8.5. Neurological Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Thoracic Surgery
  • 8.8. Urology Surgery

9. Biosurgery Market, by End-Users

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Hospitals

10. Americas Biosurgery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biosurgery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biosurgery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aroa Biosurgery Limited
  • 2. Artivion, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson, and Company
  • 6. Boston Scientific Corporation
  • 7. Cabaletta Bio, Inc.
  • 8. CSL Limited
  • 9. Getinge AB
  • 10. Hemostasis, LLC
  • 11. Integra LifeSciences Corporation
  • 12. Johnson & Johnson Services Inc.
  • 13. Kuros Bioscience AG
  • 14. Medtronic PLC
  • 15. Ocular Therapeutix, Inc.
  • 16. Orthofix Medical, Inc.
  • 17. Pfizer Inc.
  • 18. RTI Surgical, Inc.
  • 19. Samyang Holdings Corporation
  • 20. Sanofi SA
  • 21. Smith & Nephew plc
  • 22. Stryker Corporation
  • 23. Tissue Regenix Ltd
  • 24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOSURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. BIOSURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOSURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY ADHESION BARRIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY BONE GRAFT ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY SOFT TISSUE ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY BIOLOGICS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY GYNECOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY THORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY UROLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 195. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023